About AXONIS Therapeutics

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Biotechnology
Location
Location
700 Main Street, Cambridge, MA 02139, US
Description
Information
AXONIS Therapeutics is advancing breakthrough drug discoveries to develop first-in-class therapies for currently incurable neurological disorders, in order to make a real difference for patients, their families, and the global healthcare system. Operational since 2020, AXONIS is a seed-stage therapeutics company based in LabCentral, MA, and has assembled a team of world-leading innovators, serial entrepreneurs, successful drug developers, driven scientists and passionate patient advocates. Adult-onset central nervous system (CNS) disorders are an urgent, unmet, global and growing burden, especially as more people are living longer. Neuron degeneration and excitation/inhibition imbalances are fundamental problems of many debilitating neurological disorders. AXONIS is developing a pipeline of neuron-reviving therapeutics which enable an intrinsic ability of CNS neurons to: (1) resist neurodegeneration, (2) restore excitation/inhibition balance, and (3) regenerate.

AXONIS Therapeutics Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
Biotechnology
Industry
biotechnology

Frequently Asked Questions about AXONIS Therapeutics

What is AXONIS Therapeutics email format?

The widely used AXONIS Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is AXONIS Therapeutics customer service number?

To contact AXONIS Therapeutics customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more